ArticleEnvironmental research2026
Developmental PBDE exposure persistently impairs mast cell function in vivo and drives sex-specific morphological and transcriptional changes in bone marrow-derived mast cells.
Article in Environmental research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
Abstract
Polybrominated diphenyl ethers (PBDEs) are synthetic flame retardants once widely used in furniture, electronics, and other consumer products. Although phased out in the early 2000s, their persistence and recycling into new materials have led to continued contamination and widespread human exposure, raising concern for infants, who are highly vulnerable to long-term neurodevelopmental, endocrine, and metabolic disruption. Whether developmental PBDE exposure affects mast cell functions, however, remains unexplored. Mast cells are conserved immune cells distributed throughout the body that act as first responders to environmental threats-including allergens, pathogens, and toxicants-by orchestrating neural, endocrine, and immune signaling. Dysregulated mast cell activity has been implicated in multisystem pathologies such as neuroinflammation, obesity, and chemical intolerance, suggesting they may contribute to vulnerabilities resulting from developmental PBDE exposure. We found that maternal exposure to ∼87 μg/kg/day PBDE during pregnancy and lactation-a dose previously linked to metabolic and neurobehavioral effects-induces persistent mast cell dysfunction in male and female mice. Adult offspring exhibited blunted anaphylaxis-associated hypothermia and plasma histamine release in vivo, as well as reduced capacity to sustain histamine and serotonin release following Mrgprb2 stimulation ex vivo. These deficits occurred without detectable changes in tissue-resident mast cell numbers or activation. Bone marrow-derived mast cells (BMMCs) revealed sex-specific alterations in storage capacity: males accumulated increased numbers of "empty" granules, whereas females displayed hypertrophy with reduced granule density. RNA sequencing further demonstrated widespread, sex-specific transcriptional changes, with minimal overlap between males and females. Nonetheless, downregulation of granule biogenesis and cytokine signaling pathways suggested shared disruption of effector functions, while divergent regulation of serotonin receptor signaling may underlie distinct morphological phenotypes. Together, these findings identify mast cells as novel immune targets of developmental PBDE exposure, reveal sex-specific mechanisms of dysfunction, and highlight mast cells as potential mediators linking toxicant exposure to long-term multisystem vulnerabilities.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.